Clinical pharmacology profile of care in Hepatology clinic
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC MEDICA BRASILEIRA
Citação
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.63, n.5, p.401-406, 2017
Resumo
Since 2010, the Clinical Gastroenterology and Hepatology Division of the Central Institute of Hospital das Clinicas of the University of Sao Paulo Medical School (HC-FMUSP, in the Portuguese acronym) has been developing specialized electives assistance activities in the Outpatient Specialty Clinic, Secondary Level, in Sao Paulo NGA-63 Varzea do Carmo. The objective of this study was to analyze the pharmacotherapeutic profile of patients. This is a cross-sectional and retrospective study in which patients were seen at the Hepatology sector and the results were submitted to descriptive statistics. During the study period, 492 patients were treated at the clinic, with a mean age of 58.9 years and frequency of 61.2% female and 74.8% living in Sao Paulo. This population was served by various other medical specialties (cardiology and endocrine among others) and the major liver diagnoses were: chronic hepatitis B and C and fatty liver. Comorbidities were also identified, such as diabetes, hypertension and dyslipidemia. Most patients took their medication in the Basic Health Units. We found that 30% of patients use of more than five medications and the most prescribed were omeprazole 208 (42.3%), metformin 132 (26.8%) and losartan 80 (16.3%). Because it is an adult/elderly population, with several comorbidities and polymedication, it is important to be aware of the rational use of medication. The multidisciplinary team is important in applying correct conducts for the safe use of medicines, to reduce the burden on health spending and improving the quality of life of patients.
Palavras-chave
hepatitis, drug, polypharmacy, ambulatory care, hematology, omeprazole
Referências
- Abbasinazari M, 2014, IRAN J PHARM RES, V13, P1221
- Alves MLF, 2015, REV MED MINAS GERAIS, V25, P469
- Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717
- Bjerrum L, 1999, BRIT J GEN PRACT, V49, P195
- Bookman ID, 2006, LIVER INT, V26, P566, DOI 10.1111/j.1478-3231.2006.01256.x
- Brouwer WP, 2016, CLIN GASTROENTEROL H, V14, P1481, DOI 10.1016/j.cgh.2016.01.019
- Brunt EM, 2004, SEMIN LIVER DIS, V24, P3
- Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
- Cotta LSF, 2011, INFARMA, V23, P32
- D'Amico Gennaro, 2012, Hepatology, V55, P642, DOI 10.1002/hep.24695
- Hwang Y, 2015, KOREAN J INTERN MED, V30, P792, DOI 10.3904/kjim.2015.30.6.792
- Iida Vivian Helena, 2005, J. Bras. Patol. Med. Lab., V41, P29, DOI 10.1590/S1676-24442005000100008
- Invernizzi F, 2016, LIVER INT, V36, P100, DOI 10.1111/liv.13006
- Jimenez-Perez M, 2016, WORLD J GASTROENTERO, V22, P6573, DOI 10.3748/wjg.v22.i29.6573
- Brasil. Ministerio da Saude, 2013, PROT CLIN DIR TER TR
- Brasil. Ministerio da Saude, 2015, PROT CLIN DIR TER TR
- Oliveira JEP, 2015, DIRETRIZES SOC BRASI, P1
- Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050
- Serra CG, 2010, CIENC SAUDE COLETIVA, V15, P3579, DOI 10.1590/S1413-81232010000900033
- Sociedade Brasileira de Cardiologia Sociedade Brasileira de Hipertensao Sociedade Brasileira de Nefrologia, 2007, ARQ BRAS CARDIOL, V89, pe24
- Xavier HT, 2013, ARQ BRAS CARDIOL S1, V101, P1, DOI 10.5935/ABC.2013S010
- Yu ML, 2016, EXP THER MED, V12, P1103, DOI 10.3892/etm.2016.3444
- Zipprich A, 2012, Z GASTROENTEROL, V50, P996, DOI 10.1055/s-0031-1299446